Global Biologics Market Report

1. Global Biologics Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Biologics Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Biologics Market Research Report - Preface
1. 2.1 Global Biologics Market Research Report – Detailed Scope and Definitions
1. 2.1.1 By Type
2. 2.1.2 By Application
3. 2.1.3 By End-user
4. 2.1.4 By Region
3. Global Biologics Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Type, By Application, By End-user, By Country
3. 3.3. Opportunities – By Type, By Application, By End-user, By Country
4. 3.4. Trends – By Type, By Application, By End-user, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Biologics Market Research Report – DROTs Impact Analysis
4. Global Biologics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Biologics Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Monoclonal Antibodies
1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Vaccines
1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Recombinant Proteins
1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 5.4 Gene Therapies
1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 5.5 Cell Therapies
1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Biologics Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Cancer
1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Cardiovascular Diseases
1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Autoimmune Diseases
1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Infectious Diseases
1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Biologics Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Hospitals
1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Clinics
1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Biotech Companies
1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 7.4 Pharmaceutical Companies.
1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Biologics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
   1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Europe
   1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 8.3 Asia-Pacific
   1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 8.4 Latin America
   1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 8.5 Middle East & Africa
   1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.6 Global Biologics Market - Opportunity Analysis Index, By Type, By Application, By End-user, and Region, 2024 - 2031
9. North America Global Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.1.1 Monoclonal Antibodies
2. 9.1.2 Vaccines
3. 9.1.3 Recombinant Proteins
4. 9.1.4 Gene Therapies
5. 9.1.5 Cell Therapies
9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.2.1 Cancer
2. 9.2.2 Cardiovascular Diseases
3. 9.2.3 Autoimmune Diseases
4. 9.2.4 Infectious Diseases
9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.3.1 Hospitals
2. 9.3.2 Clinics
3. 9.3.3 Biotech Companies
4. 9.3.4 Pharmaceutical Companies.
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.4.1 United States
2. 9.4.2 Canada
9.5 North America Global Biologics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America Global Biologics Market Research Report - Company Profiles
1. 9.7.1 Company 1 (United States)
2. 9.7.2 Company 2 (Canada)
3. 9.7.3 Company 3 (Canada)
10. Europe Global Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.1.1 Monoclonal Antibodies
2. 10.1.2 Vaccines
3. 10.1.3 Recombinant Proteins
4. 10.1.4 Gene Therapies
5. 10.1.5 Cell Therapies
10.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.2.1 Cancer
2. 10.2.2 Cardiovascular Diseases
3. 10.2.3 Autoimmune Diseases
4. 10.2.4 Infectious Diseases
10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.3.1 Hospitals
2. 10.3.2 Clinics
3. 10.3.3 Biotech Companies
4. 10.3.4 Pharmaceutical Companies.
10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.4.1 Germany
2. 10.4.2 United Kingdom
3. 10.4.3 France
4. 10.4.4 Spain
5. 10.4.5 Italy
6. 10.4.6 Russia
7. 10.4.7 Netherlands
8. 10.4.8 Poland
9. 10.4.9 Rest of Europe
10.5 Europe Global Biologics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
10.6 Regional Trends Analysis
10.7 Europe Global Biologics Market Research Report - Company Profiles
1. 10.7.1 Company 1 (Germany)
2. 10.7.2 Company 2 (United Kingdom)
3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.1.1 Monoclonal Antibodies
2. 11.1.2 Vaccines
3. 11.1.3 Recombinant Proteins
4. 11.1.4 Gene Therapies
5. 11.1.5 Cell Therapies
11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.2.1 Cancer
2. 11.2.2 Cardiovascular Diseases
3. 11.2.3 Autoimmune Diseases
4. 11.2.4 Infectious Diseases
11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.3.1 Hospitals
2. 11.3.2 Clinics
3. 11.3.3 Biotech Companies
4. 11.3.4 Pharmaceutical Companies.
11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.4.1 China
2. 11.4.2 Japan
3. 11.4.3 India
4. 11.4.4 South Korea
5. 11.4.5 Australia & NZ
6. 11.4.6 ASEAN
7. 11.4.7 Rest of Asia-Pacific
11.5 Asia-Pacific Global Biologics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Biologics Market Research Report - Company Profiles
1. 11.7.1 Company 1 (China)
2. 11.7.2 Company 2 (Japan)
3. 11.7.3 Company 3 (Japan)
12. Latin America Global Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.1.1 Monoclonal Antibodies
2. 12.1.2 Vaccines
3. 12.1.3 Recombinant Proteins
4. 12.1.4 Gene Therapies
5. 12.1.5 Cell Therapies
12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.2.1 Cancer
2. 12.2.2 Cardiovascular Diseases
3. 12.2.3 Autoimmune Diseases
4. 12.2.4 Infectious Diseases
12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.3.1 Hospitals
2. 12.3.2 Clinics
3. 12.3.3 Biotech Companies
4. 12.3.4 Pharmaceutical Companies.
12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.4.1 Brazil
2. 12.4.2 Mexico
3. 12.4.3 Argentina
4. 12.4.4 Peru
5. 12.4.5 Colombia
6. 12.4.6 Rest of Latin America
12.5 Latin America Global Biologics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
12.6 Regional Trends Analysis
12.7 Latin America Global Biologics Market Research Report - Company Profiles
1. 12.7.1 Company 1 (Brazil)
2. 12.7.2 Company 2 (Mexico)
3. 12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Biologics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.1.1 Monoclonal Antibodies
2. 13.1.2 Vaccines
3. 13.1.3 Recombinant Proteins
4. 13.1.4 Gene Therapies
5. 13.1.5 Cell Therapies
13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.2.1 Cancer
2. 13.2.2 Cardiovascular Diseases
3. 13.2.3 Autoimmune Diseases
4. 13.2.4 Infectious Diseases
13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.3.1 Hospitals
2. 13.3.2 Clinics
3. 13.3.3 Biotech Companies
4. 13.3.4 Pharmaceutical Companies.
13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.4.1 Saudi Arabia
2. 13.4.2 UAE
3. 13.4.3 South Africa
4. 13.4.4 Egypt
5. 13.4.5 Israel
6. 13.4.6 Rest of Middle East and Africa
13.5 Middle East & Africa Global Biologics Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Biologics Market Research Report - Company Profiles
1. 13.7.1 Company 1 (Saudi Arabia)
2. 13.7.2 Company 2 (UAE)
3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)

1. 14.2.1 Biologics Market – Amgen
2. 14.2.2 Pfizer
3. 14.2.3 Roche
4. 14.2.4 Johnson & Johnson
5. 14.2.5 Novartis
6. 14.2.6 Merck & Co.
7. 14.2.7 Sanofi
8. 14.2.8 Eli Lilly
9. 14.2.9 Bristol-Myers Squibb
10. 14.2.10 AstraZeneca.
15. Data Collection Method and Research Approach
16. Principal Presumptions and Acronyms